Amyotrophic lateral sclerosis: Alterations in neurotransmitter receptors

P. J. Whitehouse, J. K. Wamsley, M. A. Zarbin, D. L. Price, W. W. Tourtellotte, M. J. Kuhar

Research output: Contribution to journalArticle

Abstract

Loss of motor neurons is the primary pathological hallmark of amyotrophic lateral sclerosis. Drug and neurotransmitter receptors are neuronal markers and can be indicators of neuronal connectivity. Knowledge of alterations in receptors in amyotrophic lateral sclerosis should contribute to our understanding of normal spinal cord neurotransmitter systems as well as of the pathophysiology of amyotrophic lateral sclerosis. We therefore used a sensitive, light microscopic in vitro labeling receptor autoradiographic technique to map and quantitate muscarinic cholinergic, glycinergic and benzodiazepine receptors in three levels of spinal cord from six patients with amyotrophic lateral sclerosis and six age- and sex-matched control patients. In control tissues, the receptor distributions were similar in the three levels of spinal cord and also similar to those found in previous studies with animals. In amyotrophic lateral sclerosis, major reductions in receptor densities were noted in Rexed layer IX, the region containing motor neurons. Reductions were noted in other laminae as well, particularly for muscarinic receptors. The changes in muscarinic receptors were caused solely by changes in high-affinity agonist sites. Reductions in glycine and muscarinic receptors were highly correlated with the degree of motor neuron loss found in the amyotrophic lateral sclerosis patients. The findings in this study point out the usefulness of this receptor mapping technique in understanding the changes in neuronal populations that occur in the degenerative neurological diseases.

Original languageEnglish (US)
Pages (from-to)8-16
Number of pages9
JournalAnnals of Neurology
Volume14
Issue number1
StatePublished - 1983

Fingerprint

Neurotransmitter Receptor
Amyotrophic Lateral Sclerosis
Muscarinic Receptors
Motor Neurons
Spinal Cord
Glycine Receptors
Drug Receptors
Cholinergic Receptors
Tissue Distribution
GABA-A Receptors
Neurotransmitter Agents
Light
Population

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Whitehouse, P. J., Wamsley, J. K., Zarbin, M. A., Price, D. L., Tourtellotte, W. W., & Kuhar, M. J. (1983). Amyotrophic lateral sclerosis: Alterations in neurotransmitter receptors. Annals of Neurology, 14(1), 8-16.

Amyotrophic lateral sclerosis : Alterations in neurotransmitter receptors. / Whitehouse, P. J.; Wamsley, J. K.; Zarbin, M. A.; Price, D. L.; Tourtellotte, W. W.; Kuhar, M. J.

In: Annals of Neurology, Vol. 14, No. 1, 1983, p. 8-16.

Research output: Contribution to journalArticle

Whitehouse, PJ, Wamsley, JK, Zarbin, MA, Price, DL, Tourtellotte, WW & Kuhar, MJ 1983, 'Amyotrophic lateral sclerosis: Alterations in neurotransmitter receptors', Annals of Neurology, vol. 14, no. 1, pp. 8-16.
Whitehouse PJ, Wamsley JK, Zarbin MA, Price DL, Tourtellotte WW, Kuhar MJ. Amyotrophic lateral sclerosis: Alterations in neurotransmitter receptors. Annals of Neurology. 1983;14(1):8-16.
Whitehouse, P. J. ; Wamsley, J. K. ; Zarbin, M. A. ; Price, D. L. ; Tourtellotte, W. W. ; Kuhar, M. J. / Amyotrophic lateral sclerosis : Alterations in neurotransmitter receptors. In: Annals of Neurology. 1983 ; Vol. 14, No. 1. pp. 8-16.
@article{4c7ff65ed36641848abb151a3ffdb335,
title = "Amyotrophic lateral sclerosis: Alterations in neurotransmitter receptors",
abstract = "Loss of motor neurons is the primary pathological hallmark of amyotrophic lateral sclerosis. Drug and neurotransmitter receptors are neuronal markers and can be indicators of neuronal connectivity. Knowledge of alterations in receptors in amyotrophic lateral sclerosis should contribute to our understanding of normal spinal cord neurotransmitter systems as well as of the pathophysiology of amyotrophic lateral sclerosis. We therefore used a sensitive, light microscopic in vitro labeling receptor autoradiographic technique to map and quantitate muscarinic cholinergic, glycinergic and benzodiazepine receptors in three levels of spinal cord from six patients with amyotrophic lateral sclerosis and six age- and sex-matched control patients. In control tissues, the receptor distributions were similar in the three levels of spinal cord and also similar to those found in previous studies with animals. In amyotrophic lateral sclerosis, major reductions in receptor densities were noted in Rexed layer IX, the region containing motor neurons. Reductions were noted in other laminae as well, particularly for muscarinic receptors. The changes in muscarinic receptors were caused solely by changes in high-affinity agonist sites. Reductions in glycine and muscarinic receptors were highly correlated with the degree of motor neuron loss found in the amyotrophic lateral sclerosis patients. The findings in this study point out the usefulness of this receptor mapping technique in understanding the changes in neuronal populations that occur in the degenerative neurological diseases.",
author = "Whitehouse, {P. J.} and Wamsley, {J. K.} and Zarbin, {M. A.} and Price, {D. L.} and Tourtellotte, {W. W.} and Kuhar, {M. J.}",
year = "1983",
language = "English (US)",
volume = "14",
pages = "8--16",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Amyotrophic lateral sclerosis

T2 - Alterations in neurotransmitter receptors

AU - Whitehouse, P. J.

AU - Wamsley, J. K.

AU - Zarbin, M. A.

AU - Price, D. L.

AU - Tourtellotte, W. W.

AU - Kuhar, M. J.

PY - 1983

Y1 - 1983

N2 - Loss of motor neurons is the primary pathological hallmark of amyotrophic lateral sclerosis. Drug and neurotransmitter receptors are neuronal markers and can be indicators of neuronal connectivity. Knowledge of alterations in receptors in amyotrophic lateral sclerosis should contribute to our understanding of normal spinal cord neurotransmitter systems as well as of the pathophysiology of amyotrophic lateral sclerosis. We therefore used a sensitive, light microscopic in vitro labeling receptor autoradiographic technique to map and quantitate muscarinic cholinergic, glycinergic and benzodiazepine receptors in three levels of spinal cord from six patients with amyotrophic lateral sclerosis and six age- and sex-matched control patients. In control tissues, the receptor distributions were similar in the three levels of spinal cord and also similar to those found in previous studies with animals. In amyotrophic lateral sclerosis, major reductions in receptor densities were noted in Rexed layer IX, the region containing motor neurons. Reductions were noted in other laminae as well, particularly for muscarinic receptors. The changes in muscarinic receptors were caused solely by changes in high-affinity agonist sites. Reductions in glycine and muscarinic receptors were highly correlated with the degree of motor neuron loss found in the amyotrophic lateral sclerosis patients. The findings in this study point out the usefulness of this receptor mapping technique in understanding the changes in neuronal populations that occur in the degenerative neurological diseases.

AB - Loss of motor neurons is the primary pathological hallmark of amyotrophic lateral sclerosis. Drug and neurotransmitter receptors are neuronal markers and can be indicators of neuronal connectivity. Knowledge of alterations in receptors in amyotrophic lateral sclerosis should contribute to our understanding of normal spinal cord neurotransmitter systems as well as of the pathophysiology of amyotrophic lateral sclerosis. We therefore used a sensitive, light microscopic in vitro labeling receptor autoradiographic technique to map and quantitate muscarinic cholinergic, glycinergic and benzodiazepine receptors in three levels of spinal cord from six patients with amyotrophic lateral sclerosis and six age- and sex-matched control patients. In control tissues, the receptor distributions were similar in the three levels of spinal cord and also similar to those found in previous studies with animals. In amyotrophic lateral sclerosis, major reductions in receptor densities were noted in Rexed layer IX, the region containing motor neurons. Reductions were noted in other laminae as well, particularly for muscarinic receptors. The changes in muscarinic receptors were caused solely by changes in high-affinity agonist sites. Reductions in glycine and muscarinic receptors were highly correlated with the degree of motor neuron loss found in the amyotrophic lateral sclerosis patients. The findings in this study point out the usefulness of this receptor mapping technique in understanding the changes in neuronal populations that occur in the degenerative neurological diseases.

UR - http://www.scopus.com/inward/record.url?scp=0020630063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020630063&partnerID=8YFLogxK

M3 - Article

C2 - 6137185

AN - SCOPUS:0020630063

VL - 14

SP - 8

EP - 16

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 1

ER -